Clinical Trial Update: Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating everolimus for uveitis unresponsive to cyclosporine A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Carsten Heinz | Conditions: Uveitis | Phase 2 | Status: COMPLETED